Table 1.
Number/sex/age (years) | Eye | Corneal pathology | Underlying ocular condition | Recipient size (mm) | Donor size (mm) | Re-bubbling times | Outcome | Follow-up period (months) |
---|---|---|---|---|---|---|---|---|
1/male/39 | OD | Chemical burn | 7.5 | 7.75 | 0 | Success | 66 | |
2/male/18 | OD | HSV keratitis | 7.5 | 8.0 | 1 | Success | 76 | |
3/female/31 | OS | SJS | Glaucoma | 7.5 | 7.75 | 1 | Success | 46 |
4/male/28 | OS | Corneal laceration | Glaucoma | 7.5 | 7.75 | 0 | Success | 45 |
5/female/55 | OS | Bacterial keratitis | PDR | 7.0 | 7.25 | 0 | Success | 64 |
6/male/5 | OS | Chemical burn | Amblyopia | 7.0 | 7.25 | 1 | Success | 72 |
7/female/35 | OD | Ocular rosacea/corneal ulcer | 7.0 | 7.25 | 0 | Success | 81 | |
8/female/34 | OS | SJS | 7.5 | 8.0 | 2 | Success | 53 | |
9/male/11 | OS | Neurotrophic keratopathy | 7.75 | 8.25 | 0 | Success | 53 | |
10/female/66 | OD | Bacterial keratitis | 7.5 | 8.0 | 2 | Success | 32 | |
11/female/77 | OS | Sicca syndrome | Dry eye | 7.5 | 7.75 | 0 | Success | 40 |
12/male/37 | OD | HSV keratitis | 8.0 | 8.25 | 2 | Success | 38 | |
13/male/9 | OD | Bacterial keratitis | 7.5 | 7.75 | 1 | Success | 72 | |
14/male/80 | OS | Neurotrophic keratopathy | 7.0 | 7.25 | 0 | Success | 87 | |
15/female/61 | OD | Penetrating trauma | Amblyopia | 7.5 | 8.0 | 0 | Success | 96 |
16/male/51 | OS | HSV keratitis | 7.5 | 7.75 | 0 | Success | 38 | |
17/male/36 | OD | Bacterial keratitis | 8.0 | 8.25 | 0 | Success | 38 | |
18/male/35 | OS | GVHD/dry eye, postcorneal ulcer | Dry eye | 7.5 | 8.0 | 0 | Success | 81 |
19/female/62 | OS | RA/dry eye, postcorneal ulcer | Dry eye | 7.5 | 7.75 | 0 | Success | 36 |
20/male/41 | OS | Neurotrophic keratopathy | Dry eye and exposure keratitis | 8.0 | 8.25 | 0 | Failure | 20 |
21/male69 | OD | Ocular rosacea/dry eye | Dry eye | 7.25 | 7.5 | 0 | Failure | 65 |
Mean age: 41.9±21.8 | 7.46±0.29 | 7.79±0.34 | 59.9±19.8 |
OD = Right eye, OS = Left eye, HSV = Herpes simplex virus, SJS = Stevens-Johnson syndrome, PDR = Proliferative diabetic retinopathy, GVHD = Graft-versus-host disease, RA = Rheumatoid arthritis